# Symbow Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/symbow-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.symbowmed.com
- Total disclosed funding: $18M
- Latest round: Series A (Jul 18, 2017)
- Investors on record: 4

## About

Symbow Medical Technology Co., Ltd. is dedicated to advancing healthcare through the development and commercialization of innovative medical devices that enhance diagnostic and therapeutic capabilities in clinical settings.Symbow Medical Technology Co., Ltd. was founded in 2011 in Beijing, China. The company focuses on creating advanced medical technology solutions without any recorded significant pivots in strategy. As of the most recent funding round, it participated in a Series A round led by HY Capital, raising CNY 120 million on July 18, 2017, with additional participation from investors including Sangel Capital, Shandong Buchang Pharmaceuticals Co., Ltd., and State Development and Investment Corporation. The company has raised a total of CNY 120 million to date.Symbow Medical Technology Co., Ltd. specializes in high-end innovative medical technology, concentrating on the development and commercialization of advanced medical devices. The core offerings include diagnostic and therapeutic equipment that address critical healthcare challenges in surgical, imaging, and patient monitoring fields, tailored for hospitals, clinics, and healthcare providers in China and select international markets.Symbow Medical Technology Co., Ltd. generates revenue through direct sales of its medical equipment and technologies to healthcare providers and institutions. The company operates on a B2B model, establishing partnerships with hospitals and medical centers that require advanced technology to enhance their healthcare services, involving bulk purchases of proprietary diagnostic devices and therapeutic tools. The pricing structure reflects regulatory compliance and advanced technology, positioning the company as a premium supplier in the medical technology sector.Symbow Medical Technology Co., Ltd. aims to leverage its recent funding from the Series A round to support the design and launch of upcoming innovative medical devices, although specific product details and release dates are not disclosed. The company plans to expand its presence into additional international markets, building upon its established foothold in major healthcare hubs and targeting regions that align with its product offerings. The capital from the CNY 120 million funding will facilitate these initiatives, helping to enhance its operational capabilities and product development efforts.

## Funding rounds

- Series A, Jul 18, 2017, $18M — State Development and Investment Corporation, Shandong Buchang Pharmaceuticals Co., Ltd., Sangel Capital, HY Capital

## Investors

- State Development and Investment Corporation (https://capitalatlas.ai/funds/state-development-and-investment-corporation) — Series A
- Shandong Buchang Pharmaceuticals Co., Ltd. — Series A
- Sangel Capital (https://capitalatlas.ai/funds/sangel-capital) — Series A
- HY Capital (https://capitalatlas.ai/funds/hy-capital) — Series A